Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients
NCT05675059 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2026-02-09
Summary
The purpose of the study is to assess the feasibility and participant satisfaction with the Support through Remote Observation and Nutrition Guidance (STRONG) program. The program provides enhanced dietician access and nutrition support for participants living with pancreatic cancer who are receiving chemotherapy.
Conditions
Interventions
- BEHAVIORAL
-
Consultations with Moffitt Dietician
Participants will have an initial consultation and then biweekly follow-up visits (in-person or virtually) with a study dietician for 12 weeks.
- BEHAVIORAL
-
Daily Food Intake Diary with Fitbit Smartphone application
Participants will keep a daily diary of food intake with a Fitbit smartphone app and wearing a Fitbit for 12 weeks.
- BEHAVIORAL
-
Questionnaires
Participants will complete a questionnaire electronically at baseline and again at 4, 8, 12 and 16 weeks.
Sponsors & Collaborators
-
Pancreatic Cancer Action Network
collaborator OTHER -
H. Lee Moffitt Cancer Center and Research Institute
lead OTHER
Principal Investigators
-
Amir Alishahi Tabriz, MD, PhD, MPH · Moffitt Cancer Center
-
Pamela Hodul, MD · Moffitt Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-21
- Primary Completion
- 2025-11-22
- Completion
- 2026-06-30
Countries
- United States
Study Locations
More Related Trials
-
Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resectable Pancreatic Cancer
NCT05836870 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Fatigue and Pancreas and Bile Duct Cancer Study
NCT00902759 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer
NCT03187951 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center
NCT06712797 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma
NCT05262855 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Photon and Proton Chemoradiotherapy as Definitive or Neoadjuvant Therapy in Non-Metastatic Pancreatic Cancer
NCT03902600 ·Status: ACTIVE_NOT_RECRUITING
-
Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study
NCT04837118 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Parenteral Nutrition Support for Patients With Pancreatic Cancer
NCT00919659 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer
NCT00651742 ·Status: COMPLETED ·Phase: PHASE2
-
Pancreatic Adenocarcinoma Gene Environment Risk Study
NCT00912717 ·Status: RECRUITING
-
Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer
NCT02432950 ·Status: COMPLETED ·Phase: NA
-
Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial
NCT05356117 ·Status: RECRUITING ·Phase: NA
-
A First-in-Human Study of FID-022 in Solid Tumor Patients
NCT07249775 ·Status: RECRUITING
-
A Supervised Prehabilitation Program for Patients With Pancreatic Cancer
NCT05692323 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic Cancer
NCT01181245 ·Status: COMPLETED ·Phase: PHASE1
-
Role of Perfusion CT in Pancreatic Cancer
NCT01703650 ·Status: UNKNOWN
-
Sequential Nutrition Intervention for Pancreatic Cancer Patients Undergoing CyberKnife Radiotherapy
NCT07057843 ·Status: COMPLETED ·Phase: NA
-
A Study of Therapy Selected by Molecular/Metabolic Profiling in Patients With Previously Treated Metastatic Pancreatic Cancer
NCT01196247 ·Status: COMPLETED ·Phase: PHASE2
-
CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas
NCT00540579 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Supportive Care Intervention-Pancreas
NCT01885884 ·Status: COMPLETED ·Phase: NA
-
Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer
NCT00761345 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
NCT05687188 ·Status: RECRUITING
-
Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
NCT06595160 ·Status: RECRUITING
-
Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer
NCT01959672 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection
NCT02750657 ·Status: COMPLETED